Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anton Langerak"'
Autor:
Pieter Martijn Kolijn, Florentin Späth, Mouhamad Khouja, Paul Hengeveld, Lina van der Straten, Nikos Darzentas, Magnus Hultdin, James D. Mckay, Christiane Pott, Roel C.H. Vermeulen, Anton Langerak
Publikováno v:
HemaSphere, Vol 7, p e61709cf (2023)
Externí odkaz:
https://doaj.org/article/f5b1ded2b4984216b04f71a13ab8b9a1
Autor:
Paul Hengeveld, Joyce Schilperoord-Vermeulen, Michèle van der Klift, Julie Dubois, Pieter Martijn Kolijn, François Kavelaars, Melissa Rijken, Johan Dobber, Kazem Nasserinejad, Sabina Kersting, Peter Westerweel, Arnon Kater, Anton Langerak, Mark-David Levin
Publikováno v:
HemaSphere, Vol 7, p e639493f (2023)
Externí odkaz:
https://doaj.org/article/efdff620d73d440c84258a3bb719f2a0
Autor:
Mouhamad Khouja, Elisa Genuardi, Simone Ferrero, Beatrice Alessandria, Onno Verhagen, Christa Homburg, Vincent H.J. van der Velden, Paula Gameiro, Ramón García-Sanz, Alejandro Medina, Eva Fronkova, Monika Brüggemann, Martin Dreyling, Eva Hoster, Anton Langerak, Nikos Darzentas, Karol Pal, Peter James Stewart, David Gonzalez, Christiane Pott
Publikováno v:
Blood. 140:3518-3520
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2cfd06325afcc5d360983b32c5ed52e
https://doi.org/10.1182/blood-2022-166043
https://doi.org/10.1182/blood-2022-166043
Autor:
Paul Hengeveld, Pieter Martijn Kolijn, Jeroen Demmers, Wouter Doff, Julie Dubois, Melissa Rijken, Jorn Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten Gussinklo, Peter Valk, Laura Faber, Peter Westerweel, Arnon Kater, Mark-David Levin, Anton Langerak
It remains challenging in chronic lymphocytic leukemia (CLL) to distinguish between patients with favorable and unfavorable time to first treatment (TTFT). Additionally, the downstream protein correlates of well-known molecular features of CLL are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f2e7a21a90fe755a7c48aee899349ac
https://doi.org/10.21203/rs.3.rs-2312822/v1
https://doi.org/10.21203/rs.3.rs-2312822/v1
Autor:
Madelon M.E. de Jong, Cathelijne Fokkema, Natalie Papazian, Teddie van Heusden, Michael Vermeulen, Sabrin Tahri, Remco Hoogenboezem, Mark van Duin, Pieter van de Woestijne, Anton Langerak, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
Publikováno v:
Blood. 140:4181-4182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc2244e7628932c9c08c7144b613c6e4
https://doi.org/10.1182/blood-2022-166339
https://doi.org/10.1182/blood-2022-166339
Autor:
Madelon de Jong, Cathelijne Fokkema, Natalie Papazian, Teddie van Heusden, Michael Vermeulen, Sabrin Tahri, Remco Hoogenboezem, Mark van Duin, Pieter van de Woestijne, Anton Langerak, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc0050643a2aef8c3be8e6e65c8c4396
https://doi.org/10.1016/s2152-2650(22)00412-8
https://doi.org/10.1016/s2152-2650(22)00412-8
Autor:
Bart Vandekerckhove, Stefanie Van Coppernolle, Greet Verstichel, Sylvia Snauwaert, Anton Langerak, Tessa Kerre
Publikováno v:
The Journal of Immunology. 188:111.6-111.6
It is well documented that in wildtype mice TCRγδ+ cells differentiate along a double negative (DN) pathway whereas TCRαβ+ cells differentiate along the double positive (DP) pathway, suggesting that the TCR itself induces lineage differentiation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4adc57ba8880eeea23e72f57ba6b4c5b
https://doi.org/10.4049/jimmunol.188.supp.111.6
https://doi.org/10.4049/jimmunol.188.supp.111.6
Autor:
Mélanie Bonnet, Marie Loosveld, Bertrand Montpellier, Jean-Marc Navarro, Benoit Quilichini, Christophe Picard, Julie Di Cristofaro, Chantal Fossat, Lucie Hernandez, Emilie Mamessier, Sandrine Roulland, Christine Formisano-Tréziny, Willem A Dik, Anton Langerak, Thomas Prebet, Norbert Vey, Gérard Michel, Jean Gabert, Jean Soulier, Elizabeth A. Macintyre, Vahid Asnafi, Dominique Payet-Bornet, Bertrand Nadel
Publikováno v:
Blood. 116:4188-4188
Abstract 4188 Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b0c03ee7495943e4d42c44b72e1e078
https://doi.org/10.1182/blood.v116.21.4188.4188
https://doi.org/10.1182/blood.v116.21.4188.4188